Видео ютуба по тегу Eli Lilly Earnings Beat

Eli Lilly posts earnings beat and raises full year guidance
Eli Lilly posts earnings beat and raises full year guidance
Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US
Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US
Eli Lilly beats on Q3 earnings, cites diabetes drug demand
Eli Lilly beats on Q3 earnings, cites diabetes drug demand
Eli Lilly and Company Q4 2025 Earnings Call
Eli Lilly and Company Q4 2025 Earnings Call
Eli Lilly Beats the Street on Q2 Revenue (NYSE:LLY)
Eli Lilly Beats the Street on Q2 Revenue (NYSE:LLY)
Eli Lilly CEO on Q2 earnings and core business performance
Eli Lilly CEO on Q2 earnings and core business performance
Eli Lilly posts EPS and revenue beat
Eli Lilly posts EPS and revenue beat
Eli Lilly Q4 2025 Blowout: $19B Revenue & $7.54 EPS Beat!
Eli Lilly Q4 2025 Blowout: $19B Revenue & $7.54 EPS Beat!
Eli Lilly posts top and bottom line beats
Eli Lilly posts top and bottom line beats
Lilly, Novo Fall on Drug Costs; Regional Banks Rise on Earnings | Stock Movers
Lilly, Novo Fall on Drug Costs; Regional Banks Rise on Earnings | Stock Movers
Eli Lilly vs Novo Nordisk | Which is the Better Stock to Buy?
Eli Lilly vs Novo Nordisk | Which is the Better Stock to Buy?
$LLY: Eli Lilly Stock Explodes After Earnings | $LLY Q4 Beat & 2026 Outlook
$LLY: Eli Lilly Stock Explodes After Earnings | $LLY Q4 Beat & 2026 Outlook
Eli Lilly Q4 Earnings: Will Obesity Drug Demand Drive LLY?
Eli Lilly Q4 Earnings: Will Obesity Drug Demand Drive LLY?
Eli Lilly Q4 2025 Earnings: Zepbound & Mounjaro EXPLODE + New
Eli Lilly Q4 2025 Earnings: Zepbound & Mounjaro EXPLODE + New "Weight Loss Pill" Launch Date
Pfizer beats estimates, Eli Lilly cuts outlook
Pfizer beats estimates, Eli Lilly cuts outlook
Drug Company Eli Lilly Misses on Earnings but Beats on Revenue
Drug Company Eli Lilly Misses on Earnings but Beats on Revenue
Eli Lilly beats on Q2 revenue and profit driven by 'a collection' of name brand drug sales: Analyst
Eli Lilly beats on Q2 revenue and profit driven by 'a collection' of name brand drug sales: Analyst
Google Cloud Powers Earnings Beat, Eli Lilly Tanks Due to Weak Weight-Loss Drug Sales
Google Cloud Powers Earnings Beat, Eli Lilly Tanks Due to Weak Weight-Loss Drug Sales
Eli Lilly Beats Estimates, Boosts Guidance
Eli Lilly Beats Estimates, Boosts Guidance
Eli Lilly CEO on quarterly earnings beat, pharma policy, and more
Eli Lilly CEO on quarterly earnings beat, pharma policy, and more